United States - English - NLM (National Library of Medicine)

rite aid - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic - to decrease bacteria on the skin that could cause disease - recommended for repeated use - irritation and redness develop - condition persists for more than 72 hours

United States - English - NLM (National Library of Medicine)

butler animal health supply - potassium gluconate (unii: 12h3k5qkn9) (potassium cation - unii:295o53k152) - potassium gluconate 468 mg - for use as a supplement in potassium deficient states in cats and dogs. each tablet contains a minimum of: potassium gluconate..............................................2 mgeq (468 mg)

United States - English - NLM (National Library of Medicine)

athenex pharmaceutical division, llc. - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - polymyxin b sulfate is a drug of choice in the treatment of infections of the urinary tract, meninges, and bloodstream caused by susceptible strains of ps. aeruginosa . it may also be used topically and subconjunctivally in the treatment of infections of the eye caused by susceptible strains of ps. aeruginosa . it may be indicated in serious infections caused by susceptible strains of the following organisms, when less potentially toxic drugs are ineffective or contraindicated: h. influenzae , specifically meningeal infections. escherichia coli , specifically urinary tract infections. aerobacter aerogenes , specifically bacteremia. klebsiella pneumoniae , specifically bacteremia. note: in meningeal infections, polymyxin b sulfate should be administered only by the intrathecal route. to reduce the development of drug-resistant bacteria and maintain the effectiveness of polymyxin b and other antibacterial drugs, polymyxin b should be used only to treat or prevent infections that are proven or strongly suspected

United States - English - NLM (National Library of Medicine)

wilshire pharmaceuticals - hydralazine hydrochloride (unii: fd171b778y) (hydralazine - unii:26nak24ls8), isosorbide dinitrate (unii: ia7306519n) (isosorbide dinitrate - unii:ia7306519n) - isosorbide dinitrate and hydralazine hydrochloride tablets are indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status. there is little experience in patients with nyha class iv heart failure. isosorbide dinitrate and hydralazine hydrochloride tablets are contraindicated in patients who are allergic to organic nitrates. do not use isosorbide dinitrate and hydralazine hydrochloride tablets in patients who are taking pde-5 inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil. concomitant use can cause severe hypotension, syncope, or myocardial ischemia [see drug interactions (7.1)] . do not use isosorbide dinitrate and hydralazine hydrochloride tablets in patients who are taking the soluble guanylate cyclase (sgc) stimulator riociguat. concomitant use can cause hypotension. risk summary there are no data on isosorbide